This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raju, B. Articles by Cryer, P. E. Search for Related Content PubMed PubMed Citation Articles by Raju, B. Articles by Cryer, P. E. Related Collections Diabetes and Insulin Metabolism

Nocturnal Hypoglycemia in Type 1 Diabetes: An Assessment of Preventive Bedtime Treatments

Division of Endocrinology, Metabolism, and Lipid Research and the General Clinical Research Center and the Diabetes Research and Training Center, Washington University School of Medicine, St. Louis, Missouri 63110

Address all correspondence and requests for reprints to: Philip E. Cryer, M.D., Campus Box 8127, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, Missouri 63110. E-mail: pcryer{at}wustl.edu.

Objective: We assessed four putative bedtime treatments in the prevention of nocturnal hypoglycemia in type 1 diabetes.

Research Design and Methods: Plasma glucose concentrations were measured every 15 min from 2200 h through 0700 h in 21 patients with type 1 diabetes (mean ± SD HbA_1C = 7.1 ± 1.0%) on five occasions with, in random sequence, bedtime (2200 h) administration of 1) no treatment, 2) a snack, 3) the snack plus the -glucosidase inhibitor acarbose, 4) an uncooked cornstarch bar, or 5) the ß₂-adrenergic agonist terbutaline.

Results: In the absence of a bedtime treatment, 27% of the measured nocturnal plasma glucose concentrations were less than 70 mg/dl (3.9 mmol/liter) in 12 patients; 16, 6, and 1% were less than 60, less than 50, and less than 40 mg/dl (3.3, 2.8, and 2.2 mmol/liter), respectively. Neither the snack (without or with acarbose) nor cornstarch raised the mean nadir nocturnal glucose concentration or reduced the number of low glucose levels or the number of patients with low levels. Terbutaline raised the mean nadir nocturnal glucose concentration (mean ± SE, 127 ± 11 vs. 75 ± 9 mg/dl; P < 0.001), eliminated glucose levels less than 50 mg/dl (P = 0.038), reduced levels less than 60 mg/dl (P = 0.005) to one, and reduced levels less than 70 mg/dl (P = 0.001) to five (four at 2215 h, one at 2230 h). However, it also raised glucose levels the following morning.

Conclusions: Nocturnal hypoglycemia is common in aggressively treated type 1 diabetes. Bedtime administration of a conventional snack or of uncooked cornstarch does not prevent it. That of terbutaline prevents nocturnal hypoglycemia but causes hyperglycemia the following morning. The efficacy of a lower dose of terbutaline remains to be determined.

This article has been cited by other articles:

				P. E. Cryer, L. Axelrod, A. B. Grossman, S. R. Heller, V. M. Montori, E. R. Seaquist, and F. J. Service Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 709 - 728. [Abstract] [Full Text] [PDF]

				S. R. Heller Minimizing Hypoglycemia While Maintaining Glycemic Control in Diabetes Diabetes, December 1, 2008; 57(12): 3177 - 3183. [Full Text] [PDF]

				B. A. Cooperberg, S. M. Breckenridge, A. M. Arbelaez, and P. E. Cryer Terbutaline and the Prevention of Nocturnal Hypoglycemia in Type 1 Diabetes Diabetes Care, December 1, 2008; 31(12): 2271 - 2272. [Abstract] [Full Text] [PDF]

				S. Al-Noori, N. M. Sanders, G. J. Taborsky Jr., C. W. Wilkinson, A. Zavosh, C. West, C. M. Sanders, and D. P. Figlewicz Recurrent hypoglycemia alters hypothalamic expression of the regulatory proteins FosB and synaptophysin Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1446 - R1454. [Abstract] [Full Text] [PDF]

				H. P. Chase Nocturnal Hypoglycemia-- An Unrelenting Problem J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2038 - 2039. [Full Text] [PDF]